Commercial Credit Assessment: CONVATEC GROUP PLC

1. Credit Opinion: CONDITIONAL

Reasoning: Convatec Group PLC is a publicly listed medical products company with established market positions in wound care, ostomy care, continence care, and infusion care. However, the financial data available through this filing is insufficient for a full credit assessment. The share capital of £419 represents nominal value only and is not indicative of the company's actual equity base or market capitalisation. As a PLC with publicly traded shares, comprehensive financial statements and annual reports are available but not captured in this data extract. A conditional approval is warranted pending receipt of audited group accounts and cash flow analysis.

2. Financial Strength

Data Limitations: The Companies House filing provides minimal financial detail. Key observations:

• Share Capital: £419 (nominal only — not reflective of true equity position)
• Group Structure: Files as "Group" category, indicating subsidiary operations
• No Balance Sheet Data: Fixed assets, current assets, net assets, and shareholders' funds are not disclosed in this extract
• PSC Register: Shows only a statement, consistent with a PLC where ownership is dispersed through public shareholding

Positive Indicators: - PLC status implies regulatory scrutiny and governance standards - Active status with no liquidation flags - Accounts not overdue — filing compliance appears strong - Medical devices sector provides defensive, non-cyclical revenue characteristics

Concerns: - Cannot assess leverage ratios, interest coverage, or tangible net worth without full accounts - Recent board turnover (two director resignations in late 2025/early 2026) warrants monitoring

3. Cash Flow Assessment

Insufficient Data: No cash flow, working capital, or liquidity metrics are available from this filing extract.

Sector Context: Medical devices and wound care typically generate: - Recurring revenue from consumable products - Strong working capital dynamics - Defensive cash flows less correlated to economic cycles

However, without actual figures, debt service coverage, free cash flow generation, and working capital adequacy cannot be evaluated.

Recommendation: Request the latest audited group annual report and interim results to assess: - EBITDA and EBITDA margins - Operating cash flow conversion - Net debt / EBITDA leverage ratio - Interest coverage ratio - Free cash flow after capital expenditure and dividends

4. Monitoring Points

Additional Considerations

Management Quality: The board demonstrates international composition (Swiss, American, British nationals), suggesting experienced leadership appropriate for a global medical products business. Professional governance structures are implied by PLC status, though recent resignations should be understood in context.

Business Resilience: The healthcare consumables sector provides natural resilience — ostomy and wound care products are non-discretionary, creating defensive revenue streams. This positions Convatec favourably during economic downturns compared to cyclical sectors.

Data Gap Advisory: This assessment is significantly constrained by the absence of financial statements. For a meaningful credit decision, the following must be obtained: - Latest annual report and accounts - Interim management statements - Net debt and liquidity position - Profitability trend over 3-5 years - Any banking facility terms and covenants